China · Delayed Price · Currency is CNY ChengDa Pharmaceuticals Statistics
Total Valuation
SHE:301201 has a market cap or net worth of CNY 5.84 billion. The enterprise value is 4.92 billion.
| Market Cap | 5.84B |
| Enterprise Value | 4.92B |
Important Dates
The next estimated earnings date is Tuesday, April 28, 2026.
| Earnings Date | Apr 28, 2026 |
| Ex-Dividend Date | Jul 10, 2025 |
Share Statistics
SHE:301201 has 151.47 million shares outstanding. The number of shares has decreased by -0.87% in one year.
| Current Share Class | 151.47M |
| Shares Outstanding | 151.47M |
| Shares Change (YoY) | -0.87% |
| Shares Change (QoQ) | +0.73% |
| Owned by Insiders (%) | 40.64% |
| Owned by Institutions (%) | 0.00% |
| Float | 71.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.60 |
| PB Ratio | 2.74 |
| P/TBV Ratio | 2.79 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 157.06 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -95.09 |
| EV / Sales | 13.14 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -28.19 |
Financial Position
The company has a current ratio of 7.38, with a Debt / Equity ratio of 0.03.
| Current Ratio | 7.38 |
| Quick Ratio | 6.23 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.33 |
| Interest Coverage | -256.48 |
Financial Efficiency
Return on equity (ROE) is -2.35% and return on invested capital (ROIC) is -6.44%.
| Return on Equity (ROE) | -2.35% |
| Return on Assets (ROA) | -1.99% |
| Return on Invested Capital (ROIC) | -6.44% |
| Return on Capital Employed (ROCE) | -3.45% |
| Weighted Average Cost of Capital (WACC) | 5.46% |
| Revenue Per Employee | 616,898 |
| Profits Per Employee | -85,211 |
| Employee Count | 656 |
| Asset Turnover | 0.16 |
| Inventory Turnover | 1.60 |
Taxes
| Income Tax | -263,409 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +108.15% in the last 52 weeks. The beta is 0.23, so SHE:301201's price volatility has been lower than the market average.
| Beta (5Y) | 0.23 |
| 52-Week Price Change | +108.15% |
| 50-Day Moving Average | 43.16 |
| 200-Day Moving Average | 31.44 |
| Relative Strength Index (RSI) | 37.37 |
| Average Volume (20 Days) | 7,182,845 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301201 had revenue of CNY 374.46 million and -51.72 million in losses. Loss per share was -0.34.
| Revenue | 374.46M |
| Gross Profit | 149.06M |
| Operating Income | -75.75M |
| Pretax Income | -51.65M |
| Net Income | -51.72M |
| EBITDA | -24.22M |
| EBIT | -75.75M |
| Loss Per Share | -0.34 |
Balance Sheet
The company has 982.90 million in cash and 58.20 million in debt, with a net cash position of 924.71 million or 6.10 per share.
| Cash & Cash Equivalents | 982.90M |
| Total Debt | 58.20M |
| Net Cash | 924.71M |
| Net Cash Per Share | 6.10 |
| Equity (Book Value) | 2.13B |
| Book Value Per Share | 14.06 |
| Working Capital | 1.12B |
Cash Flow
In the last 12 months, operating cash flow was 37.19 million and capital expenditures -211.70 million, giving a free cash flow of -174.51 million.
| Operating Cash Flow | 37.19M |
| Capital Expenditures | -211.70M |
| Free Cash Flow | -174.51M |
| FCF Per Share | -1.15 |
Margins
Gross margin is 39.81%, with operating and profit margins of -20.23% and -13.81%.
| Gross Margin | 39.81% |
| Operating Margin | -20.23% |
| Pretax Margin | -13.79% |
| Profit Margin | -13.81% |
| EBITDA Margin | -6.47% |
| EBIT Margin | -20.23% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 0.52%.
| Dividend Per Share | 0.20 |
| Dividend Yield | 0.52% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.87% |
| Shareholder Yield | 1.40% |
| Earnings Yield | -0.89% |
| FCF Yield | -2.99% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 7, 2023. It was a forward split with a ratio of 1.6.
| Last Split Date | Jul 7, 2023 |
| Split Type | Forward |
| Split Ratio | 1.6 |
Scores
SHE:301201 has an Altman Z-Score of 9.68 and a Piotroski F-Score of 2.
| Altman Z-Score | 9.68 |
| Piotroski F-Score | 2 |